2009年以降

IL-6, IL-8, IP-10, MCP-1 and G-CSF are significantly increased in cerebrospinal fluid but not in sera of patients with central neuropsychiatric lupus erythematosus.
Yoshio T, Okamoto H, Kurasawa K, Dei Y, Hirohata S, Minota S.
Lupus. 2016 Feb 3. pii: 0961203316629556.
Causes of Death in Autopsied Patients with Rheumatoid Arthritis in Japan.
Kitahama M, Okamoto H, Terai C., Koseki Y., Sakurai T., Kamatani N.
Journal of Arthritis 01/2014; 2:115. DOI: 10.4172/2167-7921.1000115
Smoking and the Microbiome in the Pathogenesis of Rheumatoid Arthritis.
Okamoto-H.
Rheumatology (Sunnyvale) 2014, 4: 132
Problems in the Management of Rheumatoid Arthritis in Rural Hospitals of Japan.
Okamoto-H.
Rheumatology (Sunnyvale) 2014, S4-009
Pregnancy In Patients With SLE
Baba S, Okamoto H. Yamanaka H,
Autoimmune Dis Ther Approaches 2015, 2:1 doi: 10.14437/ADTAOA-2-113
Environmental Factors Involved In The Pathogenesis Of Systemic Lupus Erythematosus
Okamoto-H.
Autoimmune Dis Ther Approaches 2014, 1:2 doi: 10.14437/ADTAOA-1-110
Pathogenesis of Neuropsychiatric Syndromes of Systemic Lupus Erythematosus.
Yoshio, T. and Okamoto, H.
Open Journal of Rheumatology and Autoimmune Diseases, 2015, 5, 46-56.
Morinda Citrifolia (Noni) in the Treatment of Psoriasis.
Okamoto-H.
The Open General and Internal Medicine Journal, 2012, 5, 1-2
IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells.
Yoshio T, Okamoto H, Hirohata S, Minota S.
Arthritis Rheum. 2013 Feb;65(2):457-63.
Major depressive disorder in patients with rheumatoid arthritis.
Sato E, Nishimura K, Nakajima A, Okamoto H, Shinozaki M, Inoue E, Taniguchi A, Momohara S, Yamanaka H.
Mod Rheumatol. 2013 Mar;23(2):237-44.
Systemic lupus erythematosus.
Okamoto H, Cervera R, Rodriguez-Reyna TS, Nishimura H, Yoshio T.
Autoimmune Dis. 2012;2012:815753.
Antiribosomal-P protein antibodies are associated with proliferative glomerulonephritis more strongly than with membranous glomerulonephritis in Japanese patients with systemic lupus erythematosus.
Yoshio T, Okamoto H, Onishi S, Minota S.
Mod Rheumatol. 2012 Jun;22(3):488-90.
Treatment of interstitial lung diseases associated with connective tissue diseases.
Kobayashi A, Okamoto H.
Expert Rev Clin Pharmacol. 2012 Mar;5(2):219-27.
Tyrosine kinases in rheumatoid arthritis.
Okamoto H, Kobayashi A.
J Inflamm (Lond). 2011 Aug 24;8:21.
Spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis.
Okamoto H, Kobayashi A.
N Engl J Med. 2011 Jan 6;364(1):83-4.
CISH and susceptibility to infectious diseases.
Okamoto H.
N Engl J Med. 2010 ;363:1675-6.
Molecular architecture of the Goodpasture autoantigen.
Okamoto H.
N Engl J Med. 2010 ;363:1770.
Inhibition of NF-kappaB signaling by fasudil as a potential therapeutic strategy for rheumatoid arthritis.
Okamoto H, Yoshio T, Kaneko H, Yamanaka H.
Arthritis Rheum. 2010 ;62:82-92.
Association study of TRAF1-C5 polymorphisms with susceptibility to rheumatoid arthritis and systemic lupus erythematosus in Japanese.
Nishimoto K, Kochi Y, Ikari K, Yamamoto K, Suzuki A, Shimane K, Nakamura Y, Yano K, Iikuni N, Tsukahara S, Kamatani N, Okamoto H, Kaneko H, Kawaguchi Y, Hara M, Toyama Y, Horiuchi T, Tao K, Yasumoto K, Hamada D, Yasui N, Inoue H, Itakura M, Yamanaka H, Momohara S.
Ann Rheum Dis. 2010 ;69:368-73.
Cytokines and chemokines in neuropsychiatric syndromes of systemic lupus erythematosus.
Okamoto H, Kobayashi A, Yamanaka H.
J Biomed Biotechnol. 2010;2010:268436.
Efficacy and safety of tacrolimus in 101 consecutive patients with rheumatoid arthritis.
Kitahama M, Okamoto H, Koseki Y, Inoue E, Kaneko H, Taniguchi A, Momohara S, Yamanaka H.
Mod Rheumatol. 2010 ;20:478-85.
A case of isolated gouty tophus in a patient without a previous history of gouty arthritis.
Kobayashi, S. Taniguchi A. Okamoto H. Momohara S. Tomatsu T.
Journal of Clinical Rheumatology. 2009 ;15:373.